11.16
price down icon0.36%   -0.04
after-market Handel nachbörslich: 11.21 0.05 +0.45%
loading

Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten

pulisher
Nov 15, 2024

Andreas Halvorsen's Recent Transaction in Roivant Sciences Ltd - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Roivant Sciences Ltd. (ROIV) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Vivek Ramaswamy: 10 things you ought to know about Trump's DOGE co-lead - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

Roivant Sciences Ltd - Reuters.com

Nov 14, 2024
pulisher
Nov 14, 2024

Roivant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Trump’s appointment of Ramaswamy sparks speculation on Korean biotech firms linked to Roivant - KBR

Nov 14, 2024
pulisher
Nov 13, 2024

Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new "Department of Government Efficiency" (DOGE) - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

From Vadakkanchery to top US Govt post: Vivek Ramaswamy's Kerala roots - Mathrubhumi English

Nov 13, 2024
pulisher
Nov 13, 2024

The Analyst Landscape: 5 Takes On Roivant Sciences - Benzinga

Nov 13, 2024
pulisher
Nov 13, 2024

How Vivek Ramaswamy Became A Billionaire - Forbes

Nov 13, 2024
pulisher
Nov 13, 2024

Who is Vivek Ramaswamy? What to know about Cincinnati billionaire part of Trump's Cabinet - The Cincinnati Enquirer

Nov 13, 2024
pulisher
Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: How He Built a Billion-Dollar Empire - Black Star News

Nov 13, 2024
pulisher
Nov 13, 2024

Vivek Ramaswamy's journey from bright son of immigrants to being Donald Trump's pick - The Economic Times

Nov 13, 2024
pulisher
Nov 13, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: Salary, Net Worth in Rupees (INR), Annual Income, Houses, and Cars. - Jagran Josh

Nov 13, 2024
pulisher
Nov 13, 2024

Who Is Vivek Ramaswamy, The Biotech Entrepreneur Now Part Of Trump 2.0 - NDTV

Nov 13, 2024
pulisher
Nov 13, 2024

Vivek Ramaswamy Net Worth: How this key Trump aide built his billion-dollar empire - Moneycontrol

Nov 13, 2024
pulisher
Nov 13, 2024

Roivant Sciences Ltd (ROIV) Q2 2024 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new 'Department of - The Times of India

Nov 13, 2024
pulisher
Nov 13, 2024

Vivek Ramaswamy Net Worth: From Transforming 'Ailing' Pharma To Betting On Crypto; How Trump’s Key Aide Built His Empire - Jagran English

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC Bolsters Stake in Roivant Sciences Ltd - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Roivant Sciences Reports Q2 2024 Financial Results - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Roivant Sciences earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada

Nov 12, 2024
pulisher
Nov 12, 2024

Vivek Ramaswamy's Net Worth: How Harvard-Yale graduate became rich by selling 'sick' pharma companies - The Economic Times

Nov 12, 2024
pulisher
Nov 12, 2024

Vivek Ramaswamy Net Worth: How Much Money Does the Co-Director of D.O.G.E Have? - Revista Merca2.0

Nov 12, 2024
pulisher
Nov 12, 2024

Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 2c - StreetInsider.com

Nov 12, 2024
pulisher
Nov 12, 2024

Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update - The Manila Times

Nov 12, 2024
pulisher
Nov 11, 2024

Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Report Preview: Wha - GuruFocus.com

Nov 11, 2024
pulisher
Nov 06, 2024

ROIVWroivw Latest Stock News & Market Updates - StockTitan

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Roivant Sciences L - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Roivant Sciences (ROIV) to Release Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by Impax Asset Management Group plc - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Allspring Global Investments Holdings LLC Sells 115,694 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 04, 2024
pulisher
Oct 29, 2024

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024 - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Organon Completes Acquisition of Dermavant - njbmagazine.com

Oct 29, 2024
pulisher
Oct 29, 2024

China Universal Asset Management Co. Ltd. Boosts Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Organon completes Dermavant Sciences acquisition By Investing.com - Investing.com Canada

Oct 29, 2024
pulisher
Oct 28, 2024

Organon completes Dermavant Sciences acquisition - Investing.com

Oct 28, 2024
pulisher
Oct 28, 2024

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% - StockTitan

Oct 28, 2024
pulisher
Oct 23, 2024

At Roivant Sciences, Eric Venker Chooses To Exercise Options, Resulting In $782K - Benzinga

Oct 23, 2024
pulisher
Oct 23, 2024

Options Exercise: Eric Venker At Roivant Sciences Realizes $782K - Benzinga

Oct 23, 2024
pulisher
Oct 22, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 100,000 Shares - MarketBeat

Oct 22, 2024
pulisher
Oct 22, 2024

Roivant Sciences president sells $1.17 million in shares By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Roivant Sciences president sells $1.17 million in shares - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility (ROIV) - Seeking Alpha

Oct 22, 2024
pulisher
Oct 22, 2024

Leerink maintains outperform on Roivant with steady target By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 20, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 20, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):